Raman light test for bile duct cancer diagnosis
Part of Cancer clinical trials.
This study tests a special light technique (Raman spectroscopy) to see if it can help diagnose cancer in the bile ducts outside the liver. It could be an option for people already needing an ERCP procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with cancer in the bile ducts outside the liver (extrahepatic cholangiocarcinoma).
- Your doctor has recommended an ERCP procedure as part of your care.
- You agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether DNA fragments in bile can help doctors tell if a bile duct stricture is cancerous or not. It may provide a less invasive way to get a clear diagnosis.
This study tests a new digital scope and ultrasound to look at narrowed bile ducts that don't cause jaundice. It may help doctors see the narrowing more clearly and guide treatment.
This study compares two different devices used during a procedure called ERCP to look at and take samples from a narrowed bile duct. The goal is to see which one is better at helping doctors diagnose the cause of the narrowing.
This study looks at a new way to detect bile duct cancer (cholangiocarcinoma) using samples taken during a routine ERCP. It tests a special protein marker that might help doctors diagnose the condition more accurately.
This trial uses a bile sample to help diagnose the cause of a bile duct stricture (a narrowing) that was not clearly identified by standard tests. It may help patients avoid more invasive procedures.
This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.
Hear when a new Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.